News
What’s happening in NF1 research today
New Research Tools Available in the Search for Therapies for Neurofibromatosis Type 1 Plexiform Neurofibromas
New Research Tools Available in the Search for Therapies for Neurofibromatosis Type 1 Plexiform Neurofibromas By Cathy Gara | For Release: June 15, 2018 Plexiform neurofibromas affect up to 50 percent of people with neurofibromatosis […]
Read MoreNTAP announces Dr. Angela Hirbe (Washington University) and Dr. Ping Chi (Memorial Sloan Kettering Cancer Center) have been selected as the 2017 recipients of the Francis S. Collins Scholars Award in Neurofibromatosis Clinical and Translational Research
The Neurofibromatosis Therapeutic Acceleration Program (NTAP) at The Johns Hopkins School of Medicine is proud to announce that Dr. Angela Hirbe (Washington University) and Dr. Ping Chi (Memorial Sloan Kettering Cancer Center) have been selected […]
Read MoreCutaneous Neurofibroma Initiative Projects (2018)
9 Projects Transforming the Field of NF1 Research NTAP convenes symposiums on a regular basis to determine research priorities, define new avenues of inquiry and develop requests for applications (RFAs) in neurofibromatosis type-1 (NF1) research […]
Read MoreNTAP 2018 Cutaneous Neurofibroma Initiative: 4 Supplement Paper summaries
As a result of the 2018 Cutaneous Neurofibroma Initiative, several working groups were formed to produce papers addressing key challenges identified. Those papers are summarized below with links to the full papers provided. This information […]
Read MoreNTAP and CTF supported early-phase trial demonstrates shrinkage in pediatric neural tumors
Bethesda, MD (December 28, 2016) NCI Press Release: In an early-phase clinical trial of a new oral drug, selumetinib, children with the common genetic disorder neurofibromatosis type 1 (NF1) and plexiform neurofibromas, tumors of the […]
Read MoreNTAP Announces latest Francis S. Collins Scholar, Dr. Ashley Cannon
Baltimore, MD (January 3, 2017) Ashley Cannon, Ph.D., M.S., has been named the 2016 winner of the Francis S. Collins Scholars Program in Neurofibromatosis Clinical and Translational Research, sponsored by the Neurofibromatosis Therapeutic Acceleration Program […]
Read MoreNTAP 2016 Cutaneous Neurofibroma Symposium
Establishing priorities and advancing the field of NF1 research Introduction to NTAP symposiaNTAP convenes leading researchers and innovators from across multiple fields and scientific backgrounds in regular symposia to establish priorities for the future NF1-related […]
Read MoreNTAP Selected as Innovator Presenter for Partnering for Cures Meeting
Baltimore, MD (October 1, 2014) Neurofibromatosis Therapeutic Acceleration Program (NTAP) today announced that they have been selected as an Innovator Presenter at the 6th Annual Partnering for Cures meeting to be held in New York, […]
Read MoreJohns Hopkins Announces Winners of Francis S. Collins Scholar Award
Baltimore, MD (June 9, 2014) Two early career physician-scientists, Peter de Blank and Matthew R. Steensma, have been named inaugural winners of the Francis S. Collins Scholars Program in Neurofibromatosis Clinical and Translational Research, sponsored […]
Read MoreNTAP Announces Request for Proposals to Develop Patient Reported Outcome Measures
Baltimore, MD (March 15, 2013) Neurofibromatosis Therapeutic Acceleration Program (NTAP) today announced a request for proposals (RFP) for the development of Patient Reported Outcome (PRO) measures that can be used to support clinical development of […]
Read MoreNTAP Announces Biomarker Development Idea Challenge
Baltimore, MD (January 15, 2013) Neurofibromatosis Therapeutic Acceleration Program (NTAP) today announced the launch of an idea challenge for the development of biomarkers for neurofibromatosis type 1 (NF1)-associated plexiform neurofibromas (pNF). Individuals with pNF can […]
Read MoreNTAP Announces Request for Proposals to Develop Cell Culture Models of Plexiform Neurofibromas
[vc_row][vc_column][vc_column_text margin_bottom=”10″]Baltimore, MD (October 1, 2012) Neurofibromatosis Therapeutic Acceleration Program (NTAP) today announced a request for proposals (RFP) for the development of novel cell culture models for neurofibromatosis type 1 (NF1)-associated plexiform neurofibromas (pNF). Cell […]
Read More